CURRENT AFFAIRS

Detailed explanation-1: -VINCOV-19 is a joint effort of the University of Hyderabad (UoH), the Centre for Cellular and Molecular Biology (CCMB) and VINS Bioproducts Limited. The phase 2 clinical trial of the drug in over 200 participants was done in September 2022.

Detailed explanation-2: -VINCOV-19 comprises highly purified F(ab’)2 antibody fragments that have a high neutralizing capacity against the SARS-CoV-2 virus.

Detailed explanation-3: -We present here the first case of COVID-19 infection reported in Kerala, India. On January 27, 2020, a 20 yr old female presented to the Emergency Department in General Hospital, Thrissur, Kerala, with a one-day history of dry cough and sore throat.